James W. Black
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Sir James Whyte Black, OM, FRS, FRSE, FRCP (born 14 July 1924) is a Scottish pharmacologist who invented Propranolol, synthesized Cimetidine and was awarded the Nobel Prize for Medicine in 1988 for these discoveries.[1]
Black was educated at Beath High School, Cowdenbeath, Fife, Scotland, and the University of St Andrews, Fife, where he studied medicine, spending time in Dundee (where all the clinical medical activity of St Andrews' University took place until 1967). He joined the Physiology department at University of St Andrews before taking a lecturer position at the University of Malaya. Upon return to Scotland in 1950, he joined the University of Glasgow (Veterinary School) where he established the Physiology Department. During his career he worked in both industry and academia. He was employed by ICI Pharmaceuticals (1958-1964), Smith, Kline and French (1964-1973) and Wellcome Foundation (1978-1984) and was appointed professor of pharmacology at University College London (1973-1978) and King's College London (1984-1992). He was elected a Fellow of the Royal Society in 1976 and the same year he was awarded the Lasker award. [1]. In 1979, he was awarded the Artois-Baillet Latour Health Prize.
He was created a Knight Bachelor in 1981. In 2000 Sir James was appointed to the Order of Merit by Queen Elizabeth II. The order is limited to 24 members and is the highest honour the monarch can bestow.
Sir James Black contributed to basic scientific and clinical knowledge in cardiology, both as a physician and as a basic scientist. His invention of propranolol the beta adrenergic receptor antagonist that revolutionized the medical management of angina pectoris, is considered to be one of the most important contributions to clinical medicine and pharmacology of the 20th century.[1] [1] His method of research, his discoveries about adrenergic pharmacology, and his clarification of the mechanisms of cardiac action are all strengths of his work.[1]
Sir James was the Chancellor of the University of Dundee between 1992 and May 2006. In August 2006, the Sir James Black Centre was officially incorporated into the College of Life Sciences at the university.
See also
- George H. Hitchings and Gertrude B. Elion - joint recipients of the 1988 Nobel prize in Medicine
References
| Academic offices | ||
|---|---|---|
| Preceded by Earl of Dalhousie | Chancellor of the University of Dundee 1992-2006 | Succeeded by Baron Patel |
de:James Whyte Blackit:James W. Black nl:James Black ja:ジェームス・ブラックfi:James W. Black sv:James W. Black
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
